Letters to the Editor

Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab

Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome
Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome
Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome
Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome
Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome
Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome
Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome
Italian Group for Adult Hematologic Diseases (GIMEMA) Foundation, Rome
Hematology, Department of Medical Sciences, University of Ferrara, Ferrara
Hematology, Department of Medical Sciences, University of Ferrara, Ferrara
Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome
Hematology, Department of Translational and Precision Medicine, ‘Sapienza’ University, Rome
Department of Molecular Medicine, “Sapienza” University, Rome, Italy
Haematologica Early view Oct 5, 2020 https://doi.org/10.3324/haematol.2020.262071